Longevity Vision Fund has 1 portfolio company on record at Recent Funding. Its most recent investment on record is Biolinq's $100M Series B+ round in November 2021, alongside T&W Medical, The Broe Group, Taisho Pharmaceutical Holdings and 6 others. That company is in Health and bio.

What Longevity Vision Fund invests in

• Health and bio · 1 · 100%
• Data and analytics · 1 · 100%

How Longevity Vision Fund invests

Share is of the 1 round on Recent Funding that name Longevity Vision Fund. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Longevity Vision Fund portfolio companies

• BBiolinq$100MSeries B+ · Nov 2021

Most frequent co-investors

• SSenvest Management1 shared round · last Nov 2, 2021
• TTaisho Pharmaceutical Holdings1 shared round · last Nov 2, 2021
• RRiverVest1 shared round · last Nov 2, 2021
• MM Ventures1 shared round · last Nov 2, 2021
• HHikma Ventures1 shared round · last Nov 2, 2021
• JJDRF T1D Fund1 shared round · last Nov 2, 2021
• TT&W Medical1 shared round · last Nov 2, 2021
• TThe Broe Group1 shared round · last Nov 2, 2021
• GGlobal Health Funds1 shared round · last Nov 2, 2021

Similar investors

• 221501 company · 1 deal in 12 mo
• CCove Hill Partners1 company · 1 deal in 12 mo
• DDSW Ventures1 company · 1 deal in 12 mo
• FF2 Venture Capital1 company · 1 deal in 12 mo
• NNorth Bridge Venture Partners & Growth Equity1 company
• CCastrum Capital2 companies · 2 deals in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Longevity Vision Fund, which is a subset of its real portfolio. API: /api/v1/investors/longevity-vision-fund (get a free API key). More: the most active VC firms and new venture capital funds.